Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$83.47 USD
+1.20 (1.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $83.47 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 21% (53 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.95 | 9.99 |
Current Quarter Estimate | 0.99 | 1.57 | 61.00 |
Year Ago Quarter Estimate | 1.07 | -0.94 | 54.84 |
Next Quarter Estimate | 1.00 | 1.79 | 63.00 |
Next Year Estimate | 4.13 | 6.83 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 2.49 | 21.80 | 15.67 |
Next Year | 0.49 | 7.30 | 11.34 |
Last 5 Years | 17.00 | 0.10 | 8.10 |
Next 5 Years | 11.10 | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 20.87 | 3.28 |
Price/Book (MRQ) | 3.94 | 2.01 |
Price/Cash Flow (MRFY) | 16.47 | 11.53 |
Dividend Yield | 0.48% | 0.00% |
Net Profit Margin (TTM) | 19.28% | -71.99% |
Return on Equity (TTM) | 20.32% | -48.41% |
Debt to Equity (MRQ) | 0.02 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.